Lieutenant Governor in Council Regulation

B.C. Reg. 69/2026: Amendments to the Reporting Information Affecting Public Health Regulation

Made under the Public Health Act

How does this rule affect your organization? One Click reads it against your profile and tells you, on Canada Federal Legislative Tracking. See plans →

Get alerted when the next rule lands

New rules land on their own schedule. Pick how you want to hear about them — we email you when one appears.

Publishing to members? Embed a live rule tracker on your own site — the proposed rules in your area and the comment deadlines closing on them, updating themselves. Free, one line of HTML.

The rule, in full

219 words as published, May 05, 2026. View the original →

B.C. Reg. 69/2026, deposited April 27, 2026, under the PUBLIC HEALTH ACT [sections 111 and 113]. Order in Council 163/2026, approved and ordered April 27, 2026. On the recommendation of the undersigned, the Lieutenant Governor, by and with the advice and consent of the Executive Council, orders that (a) the Reporting Information Affecting Public Health Regulation, B.C. Reg. 167/2018, is amended as set out in the attached Appendix 1, and (b) effective May 15, 2026, the Reporting Information Affecting Public Health Regulation is amended as set out in the attached Appendix 2. — J. OSBORNE, Minister of Health; J. WHITESIDE, Presiding Member of the Executive Council.

Appendix 1

1 Section 3 (4) of the Reporting Information Affecting Public Health Regulation, B.C. Reg. 167/2018, is repealed.

Appendix 2

1 Section 1 of the Schedule to the Reporting Information Affecting Public Health Regulation, B.C. Reg. 167/2018, is amended by adding the following paragraphs: (a.1) acute flaccid paralysis; (b.1) anaplasmosis; (c.1) babesiosis; (e.1) California serogroup viruses; (o.1) ehrlichiosis; . 2 Section 2 of the Schedule is amended by adding the following paragraph: (v.1) Powassan virus; . 3 Section 3 of the Schedule is amended (a) by adding the following paragraphs: (b.1) respiratory syncytial virus; (c.1) Rocky Mountain spotted fever; (l.1) tick-borne relapsing fever; , and (b) by repealing paragraph (c).